OTT KPK Romahurmuziy
Sekretaris Jenderal Kementerian Agama, M Nur Kholis Setiawan dikabarkan ikut diamankan Komisi Pemberantasan Korupsi (KPK), Jumat petang, 15 Maret 2019, menyusul OTT Ketum PPP, Romahurmuziy. Kasus ini berkaitan dengan jual beli jabatan di Kemenag.
"Dijemput di kantor tadi sore jam 5," kata salah satu staf Nur Kholis di kantor KPK kepada awak media, Jumat, 15 Maret 2019.
Selain itu, KPK juga telah menyegel ruangan, ruang kerja Menteri Agama Lukman Hakim Saefuddin dan ruang kerja Nur Kholis, sore tadi.
"Kami bantu pemeriksaan termasuk ruang menteri agama dan ruang sekjen. Informasinya baru dua itu," kata Kepala Biro Humas, Data dan Informasi Kemenag, Mastuki lewat sambungan telepon, Jumat malam.
Mastuki menerangkan, penyegelan tersebut dilakukan petugas KPK sekitar Pukul 17.30 WIB. Sebelumnya KPK telah mengantongi izin dari pihak keamanan.
"Petugas KPK datang ke kantor sudah tutup jam kantor, sekitar 17.30," kata Mastuki.
DIkonfirmasi soal penyegelan berkaitan dengan kasus Ketum PPP, Romahurmuziy oleh satgas KPK, Mastuki enggan berspekulasi. Dia menyerahkan itu kepada KPK untuk mengkonfirmasinya.
"Ditanyakan pada KPK kalau itu," imbuhnya.
Cutaneous T-Cell Lymphoma
One of the most common forms of T-cell lymphoma is cutaneous T-cell lymphoma (CTCL), a general term for T-cell lymphomas that involve the skin. CTCL can also involve the blood, lymph nodes, and other internal organs.
Symptoms can include dry skin, itching (which can be severe), a red rash, and enlarged lymph nodes. The disease affects men more often than women and usually occurs in men in their 40s, 50s, and 60s.
Most patients with CTCL experience only skin symptoms. Some patients with early stage CTCL might not progress to later stages at all, while others might progress rapidly with the cancer spreading to lymph nodes and/or internal organs.
Subtypes of CTCL
CTCL describes many different disorders with various symptoms, outcomes, and treatment considerations:
· Mycosis Fungoides (MF): the most common type of CTCL, accounting for approximately one-half of all CTCLs. MF can look different in each patient, with skin symptoms that can appear as patches, plaques, or tumors.
· Sézary Syndrome: characterized by the presence of lymphoma cells in the blood, patients with Sézary Syndrome often present with extensive thin, red, itchy rashes that typically appear on the skin.
Cutaneous T-Cell Lymphoma: Treatment Options
Many factors are considered to identify the most appropriate treatment for each patient, including the extent of skin involvement, the type of skin lesion, and whether the cancer has spread to the lymph nodes or other internal organs.
For mycosis fungoides, treatment is either directed at the skin or the entire body (systemic). Many patients live normal lives while they treat their disease, and some are able to remain in remission for long periods of time.
Since Sézary syndrome is systemic, one in which both blood and skin involvement is noted, it is usually not treated with skin-directed therapies alone. Treatments may be prescribed alone or in combination to achieve the best long-term benefit.
· Skin-Directed Therapies are generally used for earlier stage disease and are typically useful for patches and limited plaques.
o Topical treatments such as corticosteroids, retinoids, imiquimod, or chemotherapy. The following topical treaments have been approved by the U.S. Food and Drug Administration (FDA):
§ Bexarotene gel (Targretin)
§ Mechlorethamine gel (Valchor)
o Local radiation
o Ultraviolet light
· Systemic Treatment may be used in more advanced stage disease and in those with earlier stage disease in whom skin-directed therapies did not help, were not tolerated, or are not available. Systemic treatments include extracorporeal photopheresis (ECP) and/or single-agent or combination chemotherapy regimens, which may include:
o Acitretin (Soriatane)
o Bexarotene capsules (Targretin)
o Interferons (alpha or gamma)
o Methotrexate tablets (Trexall)
o Romidepsin (Istodax)
o Vorinostat (Zolinza)
